An analysis examined the systemic and individual drivers of clinician burnout and strategies to help medical professionals ...

Comorbid gout is associated with an increased risk for IS in patients with atrial fibrillation, according to a nationwide cohort study.

The second universal definition of heart failure moves away from specific EF cutoffs to classify patients into clinically actionable groups.

The American Heart Association issued a scientific statement addressing barriers to hypertension management in rural communities.

The American College of Cardiology issued a 2026 scientific statement on direct oral anticoagulants for the prevention of thrombotic events.

White matter disease detected on CT may indicate a higher risk for future stroke or dementia compared with disease detected only on MRI.

Elevated interleukin-6 levels are associated with an increased risk for adverse cardiovascular and mortality outcomes.

The American College of Cardiology released a 2026 scientific statement on antiplatelet therapy for atherosclerotic cardiovascular disease.

This article examines the risk factors, clinical presentation, and management strategies for patients with aortic dissection, the cause of the death of Sen Lindsey Graham.

FDA Drug Approvals and Regulatory Updates The table below is a review of notable updates that occurred in June 2026 for investigational products in development (not an inclusive list). Click on the ...

Treatments for fibrodysplasia ossificans progressiva, gastroenteropancreatic neuroendocrine tumors, HIV, influenza, and multiple myeloma are under review.

Eplontersen missed its primary composite endpoint of CV mortality and recurrent CV clinical events in the phase 3 CARDIO-TTRansform trial for ATTR-CM.